AJUCOVE Trademark

Trademark Overview


On Wednesday, August 2, 2017, a trademark application was filed for AJUCOVE with the United States Patent and Trademark Office. The USPTO has given the AJUCOVE trademark a serial number of 87553351. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 20, 2024. This trademark is owned by Glaxo Group Limited. The AJUCOVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ajucove

General Information


Serial Number87553351
Word MarkAJUCOVE
Filing DateWednesday, August 2, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 20, 2024
Registration Number5417129
Registration DateTuesday, March 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "AJUCOVE" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 20, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Saturday, August 5, 2017NEW APPLICATION ENTERED
Tuesday, August 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 2, 2017ASSIGNED TO EXAMINER
Thursday, November 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 20, 2024CANCELLED SEC. 8 (6-YR)